The FDA's rejection of fluvoxamine as a Covid drug, explained
The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.
Stay updated with breaking news from Guidelines Panel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA made a reasonable decision — but one that still shows much of what’s wrong with our current system for emergency approvals.
U.S. regulators have rejected a request to grant emergency authorization to a cheap drug for the treatment of ...
For the first time, a federal health panel recommended against the use of ivermectin for the treatment of ...
The WHO's guidance comes as some patients and clinicians report recurring symptoms after patients finish a course of Paxlovid.
The members of COVID-19 Treatment Guidelines Panel of the NIH apparently doesn’t seem to place any value on human life. In this article, I will show several examples of this. At no time is there [...]